CYP19A1 and gestational diabetes: Specifically, in GDM women with overweight, the concentrations of E1, E2, E1/A4 and E2/T decreased significantly, representing decreased activity of cytochrome P450 aromatase (CYP19A1) in the steroidogenic pathway (Pathway 2 in Figure 3).